Jane Street Group LLC Has $4.71 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Jane Street Group LLC raised its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 28.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 65,373 shares of the company's stock after purchasing an additional 14,434 shares during the quarter. Jane Street Group LLC owned approximately 0.13% of Prestige Consumer Healthcare worth $4,713,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of PBH. Lombard Odier Asset Management USA Corp bought a new position in Prestige Consumer Healthcare in the 2nd quarter worth approximately $550,000. Sequoia Financial Advisors LLC raised its position in shares of Prestige Consumer Healthcare by 12.9% during the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company's stock worth $708,000 after acquiring an additional 1,120 shares during the last quarter. Pinnacle Associates Ltd. raised its position in shares of Prestige Consumer Healthcare by 60.3% during the third quarter. Pinnacle Associates Ltd. now owns 24,630 shares of the company's stock worth $1,776,000 after acquiring an additional 9,269 shares during the last quarter. Ariel Investments LLC lifted its stake in shares of Prestige Consumer Healthcare by 10.7% during the second quarter. Ariel Investments LLC now owns 2,835,203 shares of the company's stock valued at $195,204,000 after acquiring an additional 274,212 shares during the period. Finally, Citigroup Inc. boosted its holdings in Prestige Consumer Healthcare by 66.6% in the third quarter. Citigroup Inc. now owns 76,772 shares of the company's stock valued at $5,535,000 after acquiring an additional 30,677 shares during the last quarter. Institutional investors own 99.95% of the company's stock.

Analyst Ratings Changes

Several brokerages have weighed in on PBH. Jefferies Financial Group reissued a "hold" rating and set a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Sidoti downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price target for the company. in a research note on Monday, December 9th. DA Davidson reaffirmed a "buy" rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. Finally, StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Wednesday. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $85.25.

Prestige Consumer Healthcare Trading Down 2.0 %

Shares of PBH stock traded down $1.60 on Wednesday, reaching $78.79. The company had a trading volume of 341,900 shares, compared to its average volume of 252,632. The stock has a market cap of $3.89 billion, a PE ratio of 19.17, a PEG ratio of 2.32 and a beta of 0.49. The company has a 50-day moving average of $78.86 and a 200-day moving average of $72.90. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. Prestige Consumer Healthcare Inc. has a 12 month low of $57.95 and a 12 month high of $86.36.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.09. The firm had revenue of $283.79 million during the quarter, compared to analysts' expectations of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The business's revenue for the quarter was down .9% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.07 earnings per share. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.44 earnings per share for the current year.

Insider Activity at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 9,885 shares of the company's stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $81.97, for a total value of $810,273.45. Following the completion of the transaction, the senior vice president now owns 18,835 shares in the company, valued at $1,543,904.95. This represents a 34.42 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Ronald M. Lombardi sold 10,875 shares of the firm's stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total transaction of $898,275.00. Following the sale, the chief executive officer now owns 320,952 shares in the company, valued at approximately $26,510,635.20. The trade was a 3.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 38,810 shares of company stock worth $3,187,300 in the last quarter. Corporate insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.